Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
You must be a Standard 1 Year member to access this content.
Cooley advised DigitalOcean Holdings on the deal, while Latham & Watkins represented Cloudways. DigitalOcean Holdings, the cloud for developers, startups, and small and midsize business (SMBs),...
You must be a Standard 1 Year member to access this content.
Cooley advised Poseida Therapeutics on the deal. Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s...
You must be a Standard 1 Year member to access this content.
